Editas Medicine (EDIT) Return on Capital Employed [ROCE] (2016 - 2025)
Editas Medicine (EDIT) posted Return on Capital Employed [ROCE] of -137.71% for Q3 2025, down 57.20 percentage points from -80.51% a year earlier but up 2.47 percentage points from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Return on Capital Employed [ROCE] (2016 - 2025) Analysis & Trends
For FY2024, Editas Medicine's Return on Capital Employed [ROCE] came in at -73.19%, down 35.05 percentage points from FY2023.
- Annual Return on Capital Employed [ROCE] shows a five-year change of -38.37 percentage points (FY2019 to FY2024).
- In prior years, Editas Medicine's Return on Capital Employed [ROCE] was -38.15% in FY2023 (+4.03 pp), -42.17% in FY2022 (-8.76 pp), -33.41% in FY2021 (-5.46 pp) and -27.94% in FY2020 (+6.88 pp).
- Quarterly Return on Capital Employed [ROCE] has run from a low of -140.18% in Q2 2025 to a high of -23.69% in Q1 2021 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last six quarters, with an average year-over-year change of -36.83 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2021, with a gain of 13.61 percentage points; the weakest was Q2 2025, with a drop of 77.21 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -140.18% (Q2 2025), -113.43% (Q1 2025) and -97.59% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 17.83% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 17.92% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.28% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 19.32% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.54% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 16.66% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -5.97% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 11.86% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.76% |
| 10 | Editas Medicine | 239.69 Mn | -472.07 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -137.71% |
| Jun 30, 2025 | -140.18% |
| Mar 31, 2025 | -113.43% |
| Dec 31, 2024 | -97.59% |
| Sep 30, 2024 | -80.51% |
| Jun 30, 2024 | -62.97% |
| Mar 31, 2024 | -45.93% |
| Dec 31, 2023 | -38.57% |
| Sep 30, 2023 | -44.90% |
| Jun 30, 2023 | -48.16% |
| Mar 31, 2023 | -52.35% |
| Dec 31, 2022 | -48.85% |
| Sep 30, 2022 | -39.74% |
| Jun 30, 2022 | -32.86% |
| Mar 31, 2022 | -30.47% |
| Dec 31, 2021 | -29.70% |
| Sep 30, 2021 | -31.71% |
| Jun 30, 2021 | -24.10% |
| Mar 31, 2021 | -23.69% |
| Dec 31, 2020 | -25.60% |
API Access
Editas Medicine Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();